FDA approves updated drug labeling including new indications and dosing regimens for capecitabine tablets under Project Renewal

Back

Sectors

Explore our tailored solutions across critical market sectors to learn how we accelerate the development and commercialization of innovative drugs, devices, and diagnostics.

Back

Solutions

Approach your next product development program with the right scientific and strategic consultancy support to consistently achieve goals and meet the highest quality and compliance standards.

Consulting

Back

Delivery Models

Ensure quality, efficiency, and reliability with a customized ClinChoice delivery model that fits your unique business needs.

Back

Expertise

Explore our strengths. Discover our wide range of therapeutic expertise and specialized experience that expedites the development and commercialization of innovative drugs, devices, and diagnostics.

Back

About

We’re on a mission to contribute to a healthier and safer world by accelerating the development and commercialization of innovative drugs and devices.

FDA approves updated drug labeling including new indications and dosing regimens for capecitabine tablets under Project Renewal

By Jill Fox
June 28, 2024

Let's Build a Healthier
& Safer World, Together

Connect with ClinChoice to discover how we can support the
development and commercialization of your drug or device.

Get In Touch

Insights

Dive Into Our Latest s

FDA approves updated drug labeling including new indications and dosing regimens for capecitabine tablets under Project Renewal

Let's Build a Healthier
& Safer World, Together

Phone

Email

Address

Sectors

Solutions

Delivery Models

Expertise

About

Other Links

Insights

Dive Into Our Latest s

FDA approves updated drug labeling including new indications and dosing regimens for capecitabine tablets under Project Renewal

SHARE

Let's Build a Healthier & Safer World, Together

Let's Build a Healthier
& Safer World, Together